Existing drug shortage databases, including one managed by the U.S
doi: 10.1111/dom.15386 31 MunawarNMahatoARawatAGillFSKumarDKatwalSet al
conducted a small, multicenter, double-blinded, placebo-controlled trial that aimed to evaluate whether ipamorelin could benefit POI in bowel resection patients
This long list of advantages is sure to grow as research advances
According to research organization RAND, nearly 12% of Americans have tried drugs like Ozempic (semaglutide) or Zepbound (tirzepatide), and notably, yet another 14% are interested in procuring their own prescription for a GLP-1 medication in the future
Still, Factor has less information available about how their food and ingredients are sourced